THRIVE
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98579402
- Registration number
- 7814609
- Mark type
- Stylized text
- Filed
- 31 May 2024
- Published for opposition
- 15 Apr 2025
- Registered
- 03 Jun 2025
- Attorney of record
- Theodore J. Bielen, Jr.
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of genetically modified cells, namely research and development of manufacturing processes for the production of fit and proliferative T-cells exhibiting naive and stem cell memory phenotypes through gene editing and cell therapy manufacturing for the treatment of patients having solid tumors by eradicating metastatic cells
Owner
- Affini-T Therapeutics, Inc., Watertown, MA, US
- Affini-T Therapeutics, Inc., Watertown, MA, US
- Affini-T Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Dec 2024 — NON-FINAL ACTION E-MAILED
- 17 Dec 2024 — NON-FINAL ACTION WRITTEN
- 16 Dec 2024 — ASSIGNED TO EXAMINER
- 14 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 May 2024 — NEW APPLICATION ENTERED